Sulfamethoxazole

Sulfamethoxazole

Clinical data
Pregnancy category	C (Au, U.S.)
Routes of administration	Oral
ATC code	J01EC01 (WHO)
Legal status
Legal status	AU: S4 (Prescription only) In general: ℞ (Prescription only)
Pharmacokinetic data
Protein binding	70%
Metabolism	Hepatic acetylation and glucuronidation
Elimination half-life	10 hours
Excretion	Renal
Identifiers
IUPAC name 4-amino-N-(5-methylisoxazol-3-yl)-benzenesulfonamide
CAS Number	723-46-6
PubChem CID	5329
DrugBank	APRD00076
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C10H11N3O3S
Molar mass	253.279 g/mol
3D model (JSmol)	Interactive image
Melting point	3 °C (37.4 °F)
SMILES CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N

WikiDoc Resources for Sulfamethoxazole
Articles
Most recent articles on Sulfamethoxazole Most cited articles on Sulfamethoxazole Review articles on Sulfamethoxazole Articles on Sulfamethoxazole in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Sulfamethoxazole Images of Sulfamethoxazole Photos of Sulfamethoxazole Podcasts & MP3s on Sulfamethoxazole Videos on Sulfamethoxazole
Evidence Based Medicine
Cochrane Collaboration on Sulfamethoxazole Bandolier on Sulfamethoxazole TRIP on Sulfamethoxazole
Clinical Trials
Ongoing Trials on Sulfamethoxazole at Clinical Trials.gov Trial results on Sulfamethoxazole Clinical Trials on Sulfamethoxazole at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Sulfamethoxazole NICE Guidance on Sulfamethoxazole NHS PRODIGY Guidance FDA on Sulfamethoxazole CDC on Sulfamethoxazole
Books
Books on Sulfamethoxazole
News
Sulfamethoxazole in the news Be alerted to news on Sulfamethoxazole News trends on Sulfamethoxazole
Commentary
Blogs on Sulfamethoxazole
Definitions
Definitions of Sulfamethoxazole
Patient Resources / Community
Patient resources on Sulfamethoxazole Discussion groups on Sulfamethoxazole Patient Handouts on Sulfamethoxazole Directions to Hospitals Treating Sulfamethoxazole Risk calculators and risk factors for Sulfamethoxazole
Healthcare Provider Resources
Symptoms of Sulfamethoxazole Causes & Risk Factors for Sulfamethoxazole Diagnostic studies for Sulfamethoxazole Treatment of Sulfamethoxazole
Continuing Medical Education (CME)
CME Programs on Sulfamethoxazole
International
Sulfamethoxazole en Espanol Sulfamethoxazole en Francais
Business
Sulfamethoxazole in the Marketplace Patents on Sulfamethoxazole
Experimental / Informatics
List of terms related to Sulfamethoxazole

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Sulfamethoxazole is a sulfonamide bacteriostatic antibiotic. It is most often used as part of a synergistic combination with trimethoprim in a 5:1 ratio in co-trimoxazole, which is also known as Bactrim, Septrin, or Septra (also abbreviated SMX/TMP). Its primary activity is against susceptible forms of Streptococcus, Staphylococcus aureus, Escherichia coli, Haemophilus influenzae, and oral anaerobes. It is commonly used to treat urinary tract infections. In addition can be used as an alternative to amoxicillin-based antibiotics to treat sinusitis.

Mechanism of action

Sulfonamides are structural analogs and competitive antagonists of para-aminobenzoic acid (PABA). They inhibit normal bacterial utilization of PABA for the synthesis of folic acid, an important metabolite in DNA synthesis. The effects seen are usually bacteriostatic in nature. Folic acid is not synthesized in humans, but is instead a dietary requirement. This allows for the selective toxicity to bacterial cells (or any cell dependent on synthesizing folic acid) over human cells. Bacterial resistance to sulfamethoxazole are caused by mutations in the folic acid enzyme that prevents the drug from binding and blocking folic acid synthesis.

File:THFsynthesispathway.png

Side effects

The most common side effect of sulfamethoxazole/trimethoprim is gastrointestinal upset. Allergies to sulfa-based medications typically cause skin rashes, hives, or trouble breathing or swallowing and warrant immediate discontinuation of the medication and contact with doctor immediately. Sulfamethoxazole/trimethoprim is also known to increase blood concentrations of the drug warfarin (U.S. brand name: Coumadin) and can cause an unexpected increase in clotting time and uncontrolled bleeding. Neutropenia and thrombocytopenia also are rare adverse effects to be monitored if a patient is placed on long-term therapy.

External links

• briandeer.com Side-effects information.

See also

• trimethoprim